CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-12 | Jacobs Bruce N. Chief Financial Officer | Sale | −1,422 | $53.27 | $76K | 17,514 |
| 2022-01-12 | Jacobs Bruce N. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −15,000 | 36,974 | ||
| 2022-01-12 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +8,612 | $2.08 | $18K | 480,811 |
| 2022-01-12 | Mainolfi Nello Chief Executive Officer | Sale | −2,726 | $51.31 | $140K | 478,085 |
| 2022-01-12 | Mainolfi Nello Chief Executive Officer | Sale | −4,022 | $52.02 | $209K | 474,063 |
| 2022-01-12 | Mainolfi Nello Chief Executive Officer | Sale | −1,623 | $53.27 | $86K | 472,440 |
| 2022-01-12 | Mainolfi Nello Chief Executive Officer | Sale | −241 | $53.97 | $13K | 472,199 |
| 2022-01-12 | Mainolfi Nello Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −8,612 | 574,280 | ||
| 2022-01-11 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +16,923 | $2.08 | $35K | 489,122 |
| 2022-01-11 | Mainolfi Nello Chief Executive Officer | Sale | −9,932 | $53.68 | $533K | 479,190 |
| 2022-01-11 | Mainolfi Nello Chief Executive Officer | Sale | −6,644 | $54.42 | $362K | 472,546 |
| 2022-01-11 | Mainolfi Nello Chief Executive Officer | Sale | −347 | $55.05 | $19K | 472,199 |
| 2022-01-11 | Mainolfi Nello Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −16,923 | 582,892 | ||
| 2022-01-10 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +22,465 | $2.08 | $47K | 494,664 |
| 2022-01-10 | Mainolfi Nello Chief Executive Officer | Sale | −7,485 | $52.46 | $393K | 487,179 |
| 2022-01-10 | Mainolfi Nello Chief Executive Officer | Sale | −10,673 | $53.35 | $569K | 476,506 |
| 2022-01-10 | Mainolfi Nello Chief Executive Officer | Sale | −4,201 | $54.40 | $229K | 472,305 |
| 2022-01-10 | Mainolfi Nello Chief Executive Officer | Sale | −106 | $54.99 | $6K | 472,199 |
| 2022-01-10 | Mainolfi Nello Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −22,465 | 599,815 | ||
| 2021-12-16 | Mainolfi Nello Chief Executive Officer | Exercise or conversion | +8,000 | $2.08 | $17K | 472,199 |
Page 40 of 41 · 810 trades